NEO vs. RELY, DLO, APLD, CARG, TNET, ATHM, CNXC, YY, JOYY, and WNS
Should you be buying NeoGenomics stock or one of its competitors? The main competitors of NeoGenomics include Remitly Global (RELY), DLocal (DLO), Applied Digital (APLD), CarGurus (CARG), TriNet Group (TNET), Autohome (ATHM), Concentrix (CNXC), JOYY (YY), JOYY (JOYY), and WNS (WNS). These companies are all part of the "business services" industry.
NeoGenomics vs. Its Competitors
Remitly Global (NASDAQ:RELY) and NeoGenomics (NASDAQ:NEO) are both business services companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, profitability, dividends, risk, media sentiment and institutional ownership.
Remitly Global has higher revenue and earnings than NeoGenomics. NeoGenomics is trading at a lower price-to-earnings ratio than Remitly Global, indicating that it is currently the more affordable of the two stocks.
Remitly Global presently has a consensus price target of $27.88, indicating a potential upside of 67.22%. NeoGenomics has a consensus price target of $13.10, indicating a potential upside of 62.13%. Given Remitly Global's stronger consensus rating and higher possible upside, equities analysts clearly believe Remitly Global is more favorable than NeoGenomics.
Remitly Global has a net margin of 0.96% compared to NeoGenomics' net margin of -15.10%. Remitly Global's return on equity of 2.31% beat NeoGenomics' return on equity.
In the previous week, Remitly Global had 5 more articles in the media than NeoGenomics. MarketBeat recorded 19 mentions for Remitly Global and 14 mentions for NeoGenomics. Remitly Global's average media sentiment score of 0.98 beat NeoGenomics' score of 0.65 indicating that Remitly Global is being referred to more favorably in the media.
Remitly Global has a beta of 0.13, meaning that its share price is 87% less volatile than the S&P 500. Comparatively, NeoGenomics has a beta of 1.61, meaning that its share price is 61% more volatile than the S&P 500.
74.3% of Remitly Global shares are held by institutional investors. Comparatively, 98.5% of NeoGenomics shares are held by institutional investors. 8.1% of Remitly Global shares are held by insiders. Comparatively, 2.4% of NeoGenomics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
Remitly Global beats NeoGenomics on 14 of the 16 factors compared between the two stocks.
Get NeoGenomics News Delivered to You Automatically
Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding NEO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
NeoGenomics Competitors List
Related Companies and Tools
This page (NASDAQ:NEO) was last updated on 9/16/2025 by MarketBeat.com Staff